Compound Summary
263717-53-9
Compound Information
263717-53-9
Compound Name: | 263717-53-9 |
Compound CID: | 5040063 |
Synonyms: | 263717-53-9 PPT propyl pyrazole triol 1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole PROPYLPYRAZOLETRIOL More... |
Iupac Name: | 4-[2,5-bis(4-hydroxyphenyl)-4-propylpyrazol-3-yl]phenol |
InChI: | InChI=1S/C24H22N2O3/c1-2-3-22-23(16-4-10-19(27)11-5-16)25-26(18-8-14-21(29)15-9-18)24(22)17-6-12-20(28)13-7-17/h4-15,27-29H,2-3H2,1H3 |
InChIKey: | IOTXSIGGFRQYKW-UHFFFAOYSA-N |
Canonical Smiles: | CCCC1=C(N(N=C1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)O |
Isomeric Smiles: | CCCC1=C(N(N=C1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)O |
Molecular Weight: | 386.4 |
Molecular Formula: | C24H22N2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
263717-53-9
Molecular Weight: | 386.4 |
Molecular Formula: | C24H22N2O3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 29 |
Complexity: | 494 |
Synonyms
263717-53-9
| 263717-53-9 | 263717-53-9 |
|---|---|
263717-53-9 |
PPT |
propyl pyrazole triol |
1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole |
PROPYLPYRAZOLETRIOL |
4,4,4-(4-propyl-1H-pyrazole-1,3,5-triyl)triphenol |
UNII-0T83Y6JZPF |
0T83Y6JZPF |
4,4,4-(4-propyl-(1H)-pyrazole-1,3,5-triyl)trisphenol" |
4,4,4-(4-Propyl-1H-pyrazole-1,3,5-triyl)trisphenol |
CHEBI:64110 |
1,3,5-tris(4-hydroxyphenyl)-4-propylpyrazole |
Phenol, 4,4,4-(4-propyl-1H-pyrazole-1,3,5-triyl)tris- |
C24H22N2O3 |
4-Propyl-1,3,5-tri((4-hydroxy)phenyl)pyrazole |
4,4,4-(4-propylpyrazole-1,3,5-triyl)trisphenol |
4-2,3-bis(4-hydroxyphenyl)-4-propyl-1H-pyrazol-5-ylidene-1-cyclohexa-2,5-dienone |
propylpyrazole triol |
4-(1,5-bis(4-hydroxyphenyl)-4-propyl-1,2-dihydro-3H-pyrazol-3-ylidene)cyclohexa-2,5-dien-1-one |
PPT trisphenol compound |
SR-01000075913 |
NCGC00015511-01 |
Tocris-1426 |
Lopac-H-6036 |
Lopac0_000575 |
MLS001056593 |
SCHEMBL426190 |
CHEMBL441282 |
GTPL2819 |
DTXSID9040392 |
CHEBI:92007 |
HMS2233O06 |
HMS3261D12 |
HMS3267J14 |
HMS3412O22 |
HMS3650I12 |
HMS3676O22 |
Tox21_500575 |
1996AH |
BDBM50398935 |
MFCD03453628 |
ZINC13121898 |
AKOS024456590 |
ZINC100001833 |
CCG-204664 |
LP00575 |
SDCCGSBI-0050557.P002 |
NCGC00015511-02 |
NCGC00015511-03 |
NCGC00015511-04 |
NCGC00015511-05 |
NCGC00015511-06 |
NCGC00015511-12 |
NCGC00025159-01 |
NCGC00025159-02 |
NCGC00025159-03 |
NCGC00025159-04 |
NCGC00261260-01 |
BP162642 |
SMR000326968 |
DB-014970 |
HY-100689 |
B6735 |
CS-0019976 |
EU-0100575 |
FT-0739972 |
J3.570.983E |
E73988 |
H 6036 |
J-016401 |
SR-01000075913-1 |
SR-01000075913-3 |
SR-01000075913-6 |
SR-01000075913-9 |
1,3,5-Tri-(4-hydroxyphenyl)-4-propyl-1H-pyrazole |
BRD-K00312224-001-03-8 |
Q27088459 |
Q27163803 |
4,4\,4"-(4-Propyl-1H-pyrazole-1,3,5-triyl)trisphenol |
4-2,5-BIS(4-HYDROXYPHENYL)-4-PROPYLPYRAZOL-3-YLPHENOL |
1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole, powder, >=98% (HPLC) |
4-2,3-Bis(4-hydroxyphenyl)-4-propyl-1H-pyrazole-5(2H)-ylidene-2,5-cyclohexadiene-1-one |
Experimental Data
263717-53-9
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
263717-53-9
Statistics Data
263717-53-9
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3.000000000000000 | 1 | 1 |
Statistics Data Visualization
263717-53-9
